High Pain Intensity is a Risk Factor of Non-Resolving TMD: A Three-Year Follow-Up of a Patient Group in a Norwegian Interdisciplinary Evaluation Program.
catastrophizing
evaluation
interdisciplinary
orofacial pain
refractory pain
stress
Journal
Journal of pain research
ISSN: 1178-7090
Titre abrégé: J Pain Res
Pays: New Zealand
ID NLM: 101540514
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
10
2021
accepted:
10
03
2022
entrez:
9
5
2022
pubmed:
10
5
2022
medline:
10
5
2022
Statut:
epublish
Résumé
To investigate the outcome of patients with long-term refractory temporomandibular disorders (TMD) three years after a Norwegian interdisciplinary evaluation program with attention to patient satisfaction, function, pain, and psychosocial variables. The study population consisted of 60 long-term refractory TMD patients who were investigated by a Norwegian interdisciplinary team. A questionnaire that covered medical history, function, pain, lifestyle factors, TMD-status and follow-up from their general medical practitioner (GMP) was sent to the patients three years after the evaluation. Questionnaires that assessed function (Mandibular Functional Index Questionnaire [MFIQ] and Roland Morrison Scale [RMS]), pain intensity (General Pain Intensity questionnaire [GPI]) and psychosocial factors (Hospital Anxiety and Depression scale [HADS]); a 2-item version of the Coping Strategies Questionnaire [CSQ]) were included in the package. Thirty-nine out of 60 TMD patients completed the questionnaires. Improvements in TMD symptoms were reported in 10 patients (26%), were unchanged in 16 patients (41%) and worsened in 13 patients (33%). Only 8 patients (21%) were satisfied with the follow-up of the suggested treatments from their GMP. Significant improvements of symptoms were noted in MFIQ (jaw function), GPI (including pain intensity at maximum and suffering from pain), and CSQ (pain related catastrophizing), in all 39 TMD patients as one group. However, a subgroup analysis showed that the significant improvements were mostly within patients who reported improvement of TMD symptoms. A high pain intensity at baseline was a significant risk factor High pain intensity at baseline was a significant risk factor for poorer recovery three years after an interdisciplinary evaluation. Our data support the notion that improved coping with TMD pain includes both decreased pain intensity, CSQ and MFIQ scores.
Identifiants
pubmed: 35529313
doi: 10.2147/JPR.S341861
pii: 341861
pmc: PMC9075908
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1283-1296Informations de copyright
© 2022 Staniszewski et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
BMC Oral Health. 2018 Aug 9;18(1):138
pubmed: 30092795
Eur J Pain. 2017 Jan;21(1):188-197
pubmed: 27461164
Clin Oral Investig. 2006 Dec;10(4):261-8
pubmed: 16924558
Pain. 2006 Jan;120(1-2):69-77
pubmed: 16364548
J Headache Pain. 2013 Apr 25;14:37
pubmed: 23617409
J Orofac Pain. 1993 Spring;7(2):183-95
pubmed: 8358365
Adv Exp Med Biol. 2020;1228:233-253
pubmed: 32342462
Patient Educ Couns. 2008 Sep;72(3):359-66
pubmed: 18684582
J Orofac Pain. 2003 Winter;17(1):9-20
pubmed: 12756926
Pain. 2000 Apr;85(3):317-332
pubmed: 10781906
J Dent Res. 2016 Sep;95(10):1084-92
pubmed: 27339423
J Oral Rehabil. 2014 Jan;41(1):59-68
pubmed: 24443899
Pain. 2012 Feb;153(2):429-436
pubmed: 22154919
J Pain. 2016 Sep;17(9 Suppl):T21-49
pubmed: 27586830
J Multidiscip Healthc. 2013 Sep 23;6:365-71
pubmed: 24082788
J Headache Pain. 2015;16:528
pubmed: 26002637
Pain Res Manag. 2020 Nov 12;2020:7893023
pubmed: 33273993
JAMA Netw Open. 2021 Feb 1;4(2):e2037371
pubmed: 33591367
Eur J Pain. 2018 Oct;22(9):1606-1616
pubmed: 29754398
Cochrane Database Syst Rev. 2010 Oct 06;(10):CD004715
pubmed: 20927737
Scand J Pain. 2017 Oct;17:367-372
pubmed: 29033299
Lancet. 2019 Apr 13;393(10180):1537-1546
pubmed: 30983589
Pain. 2003 Dec;106(3):337-345
pubmed: 14659516
Pain. 2005 Jan;113(1-2):9-19
pubmed: 15621359
Pain Res Manag. 2019 Oct 7;2019:1360725
pubmed: 31687055
Lancet. 2011 Jun 25;377(9784):2226-35
pubmed: 21704872
Clin J Pain. 2011 Mar-Apr;27(3):268-74
pubmed: 21178593
Cranio. 2021 Sep 13;:1-6
pubmed: 34515609
Lancet. 2006 May 13;367(9522):1618-25
pubmed: 16698416
J Oral Facial Pain Headache. 2020 Fall;34(4):364-373
pubmed: 33290442
Clin Oral Investig. 2021 Feb;25(2):441-453
pubmed: 33409693
J Orofac Pain. 2002 Winter;16(1):48-63
pubmed: 11889659
J Multidiscip Healthc. 2019 Sep 03;12:733-747
pubmed: 31564890
Spine (Phila Pa 1976). 1983 Mar;8(2):141-4
pubmed: 6222486
J Oral Facial Pain Headache. 2016 Summer;30(3):187-202
pubmed: 27472521
Pain. 1994 Nov;59(2):175-187
pubmed: 7892015
Pain. 2003 Aug;104(3):453-469
pubmed: 12927618
N Engl J Med. 2008 Dec 18;359(25):2693-705
pubmed: 19092154
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Rehabil Med. 2001 Nov;33(6):279-83
pubmed: 11766958
J Oral Rehabil. 2018 Nov;45(11):881-889
pubmed: 29972707
Pain Res Manag. 2018 May 2;2018:7020751
pubmed: 29854038
J Orofac Pain. 2010 Spring;24(2):139-51
pubmed: 20401352
J Pain. 2011 Nov;12(11 Suppl):T102-7
pubmed: 22074748
J Oral Maxillofac Surg. 2012 Jul;70(7):1531-3
pubmed: 22542335
J Oral Rehabil. 2019 Jan;46(1):76-86
pubmed: 30125964
Br J Oral Maxillofac Surg. 2014 Nov;52(9):827-30
pubmed: 25179688
Health Technol Assess. 2020 Feb;24(7):1-224
pubmed: 32065109
J Oral Rehabil. 2018 Sep;45(9):720-729
pubmed: 29851110
Pain. 2018 Nov;159(11):2403-2413
pubmed: 30028791
Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Jul;128(1):33-42
pubmed: 30981530
J Oral Facial Pain Headache. 2014 Winter;28(1):6-27
pubmed: 24482784